Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Marcelo Di Carli and Sharmila Dorbala.
Marcelo Di Carli
Connection Strength
20.776
Sharmila Dorbala
  1. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
    View in: PubMed
    Score: 0.893
  2. Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9.
    View in: PubMed
    Score: 0.610
  3. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med. 2014 Sep; 44(5):344-57.
    View in: PubMed
    Score: 0.589
  4. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009 Jul; 2(7):846-54.
    View in: PubMed
    Score: 0.411
  5. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med. 2007 Mar; 48(3):349-58.
    View in: PubMed
    Score: 0.350
  6. Cardiac PET-CT. J Thorac Imaging. 2007 Feb; 22(1):101-6.
    View in: PubMed
    Score: 0.348
  7. Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation. J Nucl Cardiol. 2007 Jan; 14(1):53-8.
    View in: PubMed
    Score: 0.346
  8. Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease? J Am Coll Cardiol. 2006 Dec 19; 48(12):2515-7.
    View in: PubMed
    Score: 0.344
  9. Integrated PET/CT for cardiac imaging. Q J Nucl Med Mol Imaging. 2006 Mar; 50(1):44-52.
    View in: PubMed
    Score: 0.326
  10. Effect of body mass index on left ventricular cavity size and ejection fraction. Am J Cardiol. 2006 Mar 01; 97(5):725-9.
    View in: PubMed
    Score: 0.323
  11. Cardiology patient page. Exercise testing and nuclear scanning. Circulation. 2003 Apr 29; 107(16):e100-2.
    View in: PubMed
    Score: 0.268
  12. Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. JAMA Cardiol. 2022 01 01; 7(1):93-99.
    View in: PubMed
    Score: 0.245
  13. Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC Cardiovasc Imaging. 2022 Apr; 15(4):594-603.
    View in: PubMed
    Score: 0.244
  14. Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol. 2021 Nov 24.
    View in: PubMed
    Score: 0.243
  15. A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. J Am Coll Cardiol. 2021 09 28; 78(13):1385-1389.
    View in: PubMed
    Score: 0.240
  16. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2021 Sep 07.
    View in: PubMed
    Score: 0.239
  17. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2022 02; 15(2):312-321.
    View in: PubMed
    Score: 0.238
  18. Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. J Am Heart Assoc. 2021 07 06; 10(13):e018555.
    View in: PubMed
    Score: 0.236
  19. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 11; 14(11):2212-2220.
    View in: PubMed
    Score: 0.232
  20. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
    View in: PubMed
    Score: 0.228
  21. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022 Apr; 29(2):440-446.
    View in: PubMed
    Score: 0.223
  22. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2021 12; 28(6):2976-2987.
    View in: PubMed
    Score: 0.221
  23. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.220
  24. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb; 29(1):37-42.
    View in: PubMed
    Score: 0.219
  25. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.218
  26. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.
    View in: PubMed
    Score: 0.212
  27. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.212
  28. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT. J Nucl Cardiol. 2021 10; 28(5):2004-2010.
    View in: PubMed
    Score: 0.211
  29. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019 Jun; 1(2):e180018.
    View in: PubMed
    Score: 0.205
  30. Imaging of cardiac amyloidosis: Will this become a unique application for dual-isotope imaging? J Nucl Cardiol. 2020 02; 27(1):38-40.
    View in: PubMed
    Score: 0.205
  31. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2021 06; 28(3):1089-1099.
    View in: PubMed
    Score: 0.205
  32. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.205
  33. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019 06; 12(6):e005407.
    View in: PubMed
    Score: 0.205
  34. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.203
  35. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.
    View in: PubMed
    Score: 0.202
  36. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.201
  37. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019 02; 26(1):158-173.
    View in: PubMed
    Score: 0.198
  38. Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Dec; 25(6):2189-2190.
    View in: PubMed
    Score: 0.198
  39. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018 09 01; 3(9):865-870.
    View in: PubMed
    Score: 0.194
  40. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.194
  41. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.193
  42. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.188
  43. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.186
  44. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.184
  45. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.183
  46. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.181
  47. Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Fail Rev. 2017 07; 22(4):455-464.
    View in: PubMed
    Score: 0.179
  48. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.177
  49. Editor's Note. Circ Cardiovasc Imaging. 2017 03; 10(3).
    View in: PubMed
    Score: 0.175
  50. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.171
  51. SU-F-I-31: Reproducibility of An Automatic Exposure Control Technique in the Low-Dose CT Scan of Cardiac PET/CT Exams. Med Phys. 2016 Jun; 43(6):3393-3394.
    View in: PubMed
    Score: 0.166
  52. Utility of multimodality imaging in myopericarditis with aortitis. J Nucl Cardiol. 2017 06; 24(3):1103-1106.
    View in: PubMed
    Score: 0.165
  53. Utility of multimodality imaging in suspected prosthetic valve endocarditis. J Nucl Cardiol. 2016 Apr; 23(2):316-20.
    View in: PubMed
    Score: 0.160
  54. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.159
  55. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8).
    View in: PubMed
    Score: 0.157
  56. Utility of multimodality imaging in diagnosis and follow-up of aortitis. J Nucl Cardiol. 2016 Jun; 23(3):590-5.
    View in: PubMed
    Score: 0.156
  57. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016 Feb; 23(1):45-63.
    View in: PubMed
    Score: 0.156
  58. Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity. Eur J Nucl Med Mol Imaging. 2015 Sep; 42(10):1551-61.
    View in: PubMed
    Score: 0.155
  59. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.153
  60. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
    View in: PubMed
    Score: 0.152
  61. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.150
  62. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.149
  63. Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. J Am Coll Cardiol. 2014 Aug 12; 64(6):631.
    View in: PubMed
    Score: 0.147
  64. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67.
    View in: PubMed
    Score: 0.146
  65. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62.
    View in: PubMed
    Score: 0.144
  66. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.144
  67. Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. J Am Coll Cardiol. 2014 Jun 17; 63(23):2590.
    View in: PubMed
    Score: 0.143
  68. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.141
  69. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
    View in: PubMed
    Score: 0.138
  70. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
    View in: PubMed
    Score: 0.137
  71. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013 Aug; 54(8):1485-507.
    View in: PubMed
    Score: 0.135
  72. Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging. Eur Heart J. 2013 Jul; 34(27):2074-81a.
    View in: PubMed
    Score: 0.133
  73. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013 May 21; 61(20):2098-106.
    View in: PubMed
    Score: 0.133
  74. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013 Jan 15; 61(2):176-84.
    View in: PubMed
    Score: 0.130
  75. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34.
    View in: PubMed
    Score: 0.129
  76. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012 Oct 09; 126(15):1858-68.
    View in: PubMed
    Score: 0.128
  77. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8.
    View in: PubMed
    Score: 0.125
  78. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011 Oct 18; 58(17):1807-16.
    View in: PubMed
    Score: 0.121
  79. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011 Nov 15; 124(20):2215-24.
    View in: PubMed
    Score: 0.121
  80. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med. 2011 Sep; 52(9):1369-77.
    View in: PubMed
    Score: 0.119
  81. Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol. 2010 Jun; 17(3):498-513.
    View in: PubMed
    Score: 0.110
  82. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging. 2009 Nov; 2(6):429-36.
    View in: PubMed
    Score: 0.104
  83. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009 Jul; 50(7):1062-71.
    View in: PubMed
    Score: 0.102
  84. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging. 2009 Oct; 36(10):1603-10.
    View in: PubMed
    Score: 0.101
  85. Multimodality imaging of an unusual case of cardiac paraganglioma. J Nucl Cardiol. 2009 Jul-Aug; 16(4):644-7.
    View in: PubMed
    Score: 0.101
  86. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1593-601.
    View in: PubMed
    Score: 0.095
  87. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008 Apr 01; 117(13):1693-700.
    View in: PubMed
    Score: 0.094
  88. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007 Nov-Dec; 14(6):799-809.
    View in: PubMed
    Score: 0.091
  89. Clinical myocardial perfusion PET/CT. J Nucl Med. 2007 May; 48(5):783-93.
    View in: PubMed
    Score: 0.088
  90. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007 Mar 13; 49(10):1052-8.
    View in: PubMed
    Score: 0.087
  91. Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease. J Nucl Cardiol. 2006 Nov; 13(6):761-7.
    View in: PubMed
    Score: 0.085
  92. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. J Nucl Cardiol. 2006 May-Jun; 13(3):378-84.
    View in: PubMed
    Score: 0.083
  93. Integrated cardiac PET-CT for the diagnosis and management of CAD. J Nucl Cardiol. 2006 Mar-Apr; 13(2):139-44.
    View in: PubMed
    Score: 0.082
  94. Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging. Am J Cardiol. 2004 Sep 15; 94(6):703-8.
    View in: PubMed
    Score: 0.074
  95. Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure. Curr Cardiol Rep. 2003 Jan; 5(1):32-9.
    View in: PubMed
    Score: 0.066
  96. Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry. J Nucl Cardiol. 2022 Feb 16.
    View in: PubMed
    Score: 0.062
  97. Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry. J Nucl Cardiol. 2021 Nov 10.
    View in: PubMed
    Score: 0.061
  98. Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry. Circ Cardiovasc Imaging. 2021 07; 14(7):e012386.
    View in: PubMed
    Score: 0.059
  99. Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry. Cardiovasc Res. 2021 Jul 14.
    View in: PubMed
    Score: 0.059
  100. Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery Disease. JACC Cardiovasc Imaging. 2021 Jul 07.
    View in: PubMed
    Score: 0.059
  101. Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT. J Nucl Cardiol. 2021 Jul 06.
    View in: PubMed
    Score: 0.059
  102. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. Eur Heart J Cardiovasc Imaging. 2021 05 10; 22(6):705-714.
    View in: PubMed
    Score: 0.058
  103. Quantitation of Poststress Change in Ventricular Morphology Improves Risk Stratification. J Nucl Med. 2021 11; 62(11):1582-1590.
    View in: PubMed
    Score: 0.058
  104. Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry. J Nucl Cardiol. 2022 Apr; 29(2):727-736.
    View in: PubMed
    Score: 0.056
  105. Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia. JACC Cardiovasc Imaging. 2021 03; 14(3):644-653.
    View in: PubMed
    Score: 0.056
  106. Appropriate Use Criteria for PET Myocardial Perfusion Imaging. J Nucl Med. 2020 08; 61(8):1221-1265.
    View in: PubMed
    Score: 0.055
  107. A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging. JACC Cardiovasc Imaging. 2020 10; 13(10):2193-2202.
    View in: PubMed
    Score: 0.055
  108. Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry. Eur Heart J Cardiovasc Imaging. 2020 05 01; 21(5):549-559.
    View in: PubMed
    Score: 0.054
  109. Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry. Diabetes Care. 2020 02; 43(2):453-459.
    View in: PubMed
    Score: 0.053
  110. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2021 10; 28(5):1988-1997.
    View in: PubMed
    Score: 0.053
  111. 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT. JACC Cardiovasc Imaging. 2020 03; 13(3):774-785.
    View in: PubMed
    Score: 0.051
  112. Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registry. J Nucl Cardiol. 2020 08; 27(4):1180-1189.
    View in: PubMed
    Score: 0.051
  113. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
    View in: PubMed
    Score: 0.050
  114. Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study. J Nucl Med. 2019 05; 60(5):664-670.
    View in: PubMed
    Score: 0.049
  115. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.048
  116. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.048
  117. Is There an Age When Myocardial Perfusion Imaging May No Longer Be Prognostically Useful? Circ Cardiovasc Imaging. 2018 07; 11(7):e007322.
    View in: PubMed
    Score: 0.048
  118. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol. 2020 06; 27(3):1010-1021.
    View in: PubMed
    Score: 0.048
  119. Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study. JACC Cardiovasc Imaging. 2018 11; 11(11):1654-1663.
    View in: PubMed
    Score: 0.047
  120. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Feb; 25(1):269-297.
    View in: PubMed
    Score: 0.047
  121. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.046
  122. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018 02; 59(2):273-293.
    View in: PubMed
    Score: 0.046
  123. Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease. Eur J Nucl Med Mol Imaging. 2018 04; 45(4):538-548.
    View in: PubMed
    Score: 0.046
  124. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 10; 24(5):1741-1758.
    View in: PubMed
    Score: 0.046
  125. Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 08; 58(8):1341-1353.
    View in: PubMed
    Score: 0.045
  126. Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2017 12; 24(6):1966-1975.
    View in: PubMed
    Score: 0.042
  127. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.042
  128. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46.
    View in: PubMed
    Score: 0.038
  129. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.036
  130. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovasc Imaging. 2014 Mar; 7(3):278-87.
    View in: PubMed
    Score: 0.035
  131. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
    View in: PubMed
    Score: 0.035
  132. Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol. 2014 Apr; 21(2):233-44.
    View in: PubMed
    Score: 0.035
  133. Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. Eur Heart J Cardiovasc Imaging. 2014 Jul; 15(7):787-92.
    View in: PubMed
    Score: 0.035
  134. Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
    View in: PubMed
    Score: 0.035
  135. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013 Oct 29; 62(18):1639-1653.
    View in: PubMed
    Score: 0.034
  136. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol. 2013 Nov 12; 62(20):1866-76.
    View in: PubMed
    Score: 0.034
  137. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013 Apr; 20(2):310-2.
    View in: PubMed
    Score: 0.033
  138. Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging. J Nucl Cardiol. 2012 Aug; 19(4):814-7.
    View in: PubMed
    Score: 0.032
  139. Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9.
    View in: PubMed
    Score: 0.031
  140. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol. 2012 Jan 31; 59(5):462-74.
    View in: PubMed
    Score: 0.031
  141. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
    View in: PubMed
    Score: 0.027
  142. Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality. Ann Intern Med. 2008 Oct 07; 149(7):451-60, W82.
    View in: PubMed
    Score: 0.024
  143. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol. 2007 Feb 27; 49(8):855-62.
    View in: PubMed
    Score: 0.022
  144. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol. 2005 Feb 15; 45(4):553-8.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.